Several emerging compounds are gaining focus within the therapeutic community. Retatrutide, a double GLP-1 and GIP agonist, is showing potential for weight management. BPC-157, or Body Fragment 157, is thought to https://bpc157226450.wikipublicity.com/194681/retatrutide_bpc_157_ghk_cu_tb_500_a_deep_dive_into_emerging_compounds